Journal article
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
- Abstract:
-
Background
Polygenic hazard scores (PHS) can identify individuals with increased risk of prostate cancer. We estimated the benefit of additional SNPs on performance of a previously validated PHS (PHS46).
Materials and method
180 SNPs, shown to be previously associated with prostate cancer, were used to develop a PHS model in men with European ancestry. A machine-learning approach, LASSO-regularized Cox regression, was used to select SNPs and to estimate their coefficients in the training set (75,596 men). Performance of the resulting model was evaluated in the testing/validation set (6,411 men) with two metrics: (1) hazard ratios (HRs) and (2) positive predictive value (PPV) of prostate-specific antigen (PSA) testing. HRs were estimated between individuals with PHS in the top 5% to those in the middle 40% (HR95/50), top 20% to bottom 20% (HR80/20), and bottom 20% to middle 40% (HR20/50). PPV was calculated for the top 20% (PPV80) and top 5% (PPV95) of PHS as the fraction of individuals with elevated PSA that were diagnosed with clinically significant prostate cancer on biopsy.
Results
166 SNPs had non-zero coefficients in the Cox model (PHS166). All HR metrics showed significant improvements for PHS166 compared to PHS46: HR95/50 increased from 3.72 to 5.09, HR80/20 increased from 6.12 to 9.45, and HR20/50 decreased from 0.41 to 0.34. By contrast, no significant differences were observed in PPV of PSA testing for clinically significant prostate cancer.
Conclusions
Incorporating 120 additional SNPs (PHS166 vs PHS46) significantly improved HRs for prostate cancer, while PPV of PSA testing remained the same.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41391-020-00311-2
Authors
Contributors
- Role:
- Contributor
- Role:
- Contributor
- Role:
- Contributor
- Role:
- Contributor
- Role:
- Contributor
- Publisher:
- Springer Nature
- Journal:
- Prostate Cancer and Prostatic Diseases More from this journal
- Volume:
- 24
- Issue:
- 2
- Pages:
- 532-541
- Publication date:
- 2021-01-08
- Acceptance date:
- 2020-12-04
- DOI:
- EISSN:
-
1476-5608
- ISSN:
-
1365-7852
- Language:
-
English
- Keywords:
- Pubs id:
-
1152739
- Local pid:
-
pubs:1152739
- Deposit date:
-
2021-01-10
Terms of use
- Copyright holder:
- Karunamuni et al.
- Copyright date:
- 2021
- Rights statement:
- © The Author(s), under exclusive licence to Springer Nature Limited 2021
- Notes:
- This is the accepted manuscript version of the article. The final published version is available from Springer Nature at https://doi.org/10.1038/s41391-020-00311-2
If you are the owner of this record, you can report an update to it here: Report update to this record